Ko-Chung Lin
Ko-Chung Lin, Ph.D., is the founder and CEO of PharmaEssentia, a global biopharmaceutical company. He has played a crucial role in the development and approval of BESREMi®, which has been recognized as an important therapeutic option for patients with Polycythemia Vera, emphasizing the impact of international collaboration in healthcare advancements.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Venezuela:
Ko-Chung Lin, Ph.D., founder and CEO of PharmaEssentia, stated that the approval of BESREMi® is a testament to the power of strong international partnerships in advancing healthcare.
8